Department of Otolaryngology, Faculty of Medicine, 68820Al-Azhar University, Damietta, Egypt.
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, 68820Al-Azhar University, Cairo, Egypt.
Am J Rhinol Allergy. 2022 Nov;36(6):841-848. doi: 10.1177/19458924221120116. Epub 2022 Aug 9.
COVID-19 has been associated with temporary olfactory dysfunction in many infected patients. Calcium plays a great role in the olfaction process with negative feedback for the olfaction transmission. Many reports demonstrated calcium elevation in the nasal secretions with a negative effect on olfaction. Sodium gluconate is a water-soluble salt with a chemical structure that lends to act as a highly efficient chelating agent. It can bind the elevated calcium in the nasal secretions reducing the adverse effects on olfactory function.
To evaluate the impact of intranasal sodium gluconate on decreasing the rise of nasal calcium and improving the sense of smell in patients with olfactory dysfunction post-COVID-19 infection.
Fifty patients with a history of confirmed COVID-19 suffering from olfactory dysfunction persisted more than 90 days after severe acute respiratory syndrome-coronavirus-2 negative testing were included in a prospective randomized blinded controlled clinical trial. Patients were divided into 2 equal groups, receiving either 0.9% sodium chloride or 1% sodium gluconate. Olfactory function was assessed before treatment and 1 month later using the Sniffin' Sticks test. Quantitative analysis of the nasal calcium concentration was performed before treatment and 1 month later using a laboratory-designed screen-printed ion-selective electrode.
After using sodium gluconate, the measured olfactory scores indicated a clinical improvement from anosmia to hyposmia compared to the nonimprovement sodium chloride receiving group. Also, a remarked decrease in the calcium nasal concentration was observed after using sodium gluconate compared to sodium chloride.
Based on the proposed results, sodium gluconate may associate with an improvement of the olfactory dysfunction post-COVID-19 infection.
COVID-19 已与许多感染患者的暂时嗅觉功能障碍有关。钙在嗅觉过程中起着重要作用,对嗅觉传递有负反馈作用。许多报告表明,鼻分泌物中的钙升高对嗅觉有负面影响。葡萄糖酸钠是一种水溶性盐,其化学结构使其具有作为高效螯合剂的作用。它可以结合鼻分泌物中升高的钙,减少对嗅觉功能的不利影响。
评估鼻内葡萄糖酸钠对降低 COVID-19 感染后嗅觉障碍患者鼻钙升高和改善嗅觉的影响。
50 例确诊 COVID-19 病史、嗅觉障碍持续时间超过 SARS-CoV-2 阴性检测后 90 天的患者纳入前瞻性随机双盲对照临床试验。患者分为两组,每组 25 例,分别接受 0.9%氯化钠或 1%葡萄糖酸钠。使用 Sniffin' Sticks 测试在治疗前和 1 个月后评估嗅觉功能。使用实验室设计的丝网印刷离子选择性电极在治疗前和 1 个月后测量鼻钙浓度的定量分析。
使用葡萄糖酸钠后,与未改善的氯化钠组相比,嗅觉评分表明从嗅觉丧失到嗅觉减退的临床改善。与氯化钠相比,使用葡萄糖酸钠后,鼻钙浓度明显下降。
基于提出的结果,葡萄糖酸钠可能与 COVID-19 感染后嗅觉功能障碍的改善有关。